230 related articles for article (PubMed ID: 15735665)
1. topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage.
Lin L; Ozaki T; Takada Y; Kageyama H; Nakamura Y; Hata A; Zhang JH; Simonds WF; Nakagawara A; Koseki H
Oncogene; 2005 May; 24(21):3385-96. PubMed ID: 15735665
[TBL] [Abstract][Full Text] [Related]
2. DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3.
Shinbo Y; Taira T; Niki T; Iguchi-Ariga SM; Ariga H
Int J Oncol; 2005 Mar; 26(3):641-8. PubMed ID: 15703819
[TBL] [Abstract][Full Text] [Related]
3. Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo.
Weger S; Hammer E; Heilbronn R
FEBS Lett; 2005 Sep; 579(22):5007-12. PubMed ID: 16122737
[TBL] [Abstract][Full Text] [Related]
4. Topors, a p53 and topoisomerase I binding protein, interacts with the adeno-associated virus (AAV-2) Rep78/68 proteins and enhances AAV-2 gene expression.
Weger S; Hammer E; Heilbronn R
J Gen Virol; 2002 Mar; 83(Pt 3):511-516. PubMed ID: 11842245
[TBL] [Abstract][Full Text] [Related]
5. The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies.
Rasheed ZA; Saleem A; Ravee Y; Pandolfi PP; Rubin EH
Exp Cell Res; 2002 Jul; 277(2):152-60. PubMed ID: 12083797
[TBL] [Abstract][Full Text] [Related]
6. The topoisomerase I- and p53-binding protein topors is differentially expressed in normal and malignant human tissues and may function as a tumor suppressor.
Saleem A; Dutta J; Malegaonkar D; Rasheed F; Rasheed Z; Rajendra R; Marshall H; Luo M; Li H; Rubin EH
Oncogene; 2004 Jul; 23(31):5293-300. PubMed ID: 15107820
[TBL] [Abstract][Full Text] [Related]
7. Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells.
Son SH; Yu E; Choi EK; Lee H; Choi J
Cancer Gene Ther; 2005 Jan; 12(1):1-11. PubMed ID: 15529177
[TBL] [Abstract][Full Text] [Related]
8. Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53.
Rajendra R; Malegaonkar D; Pungaliya P; Marshall H; Rasheed Z; Brownell J; Liu LF; Lutzker S; Saleem A; Rubin EH
J Biol Chem; 2004 Aug; 279(35):36440-4. PubMed ID: 15247280
[TBL] [Abstract][Full Text] [Related]
9. Selective transcription of p53 target genes by zinc finger-p53 DNA binding domain chimeras.
Falke D; Fisher MH; Juliano RL
Biochim Biophys Acta; 2004 Nov; 1681(1):15-27. PubMed ID: 15566940
[TBL] [Abstract][Full Text] [Related]
10. Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein.
Haluska P; Saleem A; Rasheed Z; Ahmed F; Su EW; Liu LF; Rubin EH
Nucleic Acids Res; 1999 Jun; 27(12):2538-44. PubMed ID: 10352183
[TBL] [Abstract][Full Text] [Related]
11. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
Goldwasser F; Bae I; Fornace AJ; Pommier Y
Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
[TBL] [Abstract][Full Text] [Related]
12. The contribution of the RING finger domain of MDM2 to cell cycle progression.
Argentini M; Barboule N; Wasylyk B
Oncogene; 2000 Aug; 19(34):3849-57. PubMed ID: 10951578
[TBL] [Abstract][Full Text] [Related]
13. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
14. DNA damage, c-myc suppression and apoptosis induced by the novel topoisomerase II inhibitor, salvicine, in human breast cancer MCF-7 cells.
Lu HR; Meng LH; Huang M; Zhu H; Miao ZH; Ding J
Cancer Chemother Pharmacol; 2005 Mar; 55(3):286-94. PubMed ID: 15592835
[TBL] [Abstract][Full Text] [Related]
15. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
16. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
Jacob S; Aguado M; Fallik D; Praz F
Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis and growth arrest induced by platinum compounds in U2-OS cells reflect a specific DNA damage recognition associated with a different p53-mediated response.
Gatti L; Supino R; Perego P; Pavesi R; Caserini C; Carenini N; Righetti SC; Zuco V; Zunino F
Cell Death Differ; 2002 Dec; 9(12):1352-9. PubMed ID: 12478472
[TBL] [Abstract][Full Text] [Related]
18. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
19. p53-inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: suppression by BAG-1.
Matsuzawa S; Takayama S; Froesch BA; Zapata JM; Reed JC
EMBO J; 1998 May; 17(10):2736-47. PubMed ID: 9582267
[TBL] [Abstract][Full Text] [Related]
20. Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells.
Yang HL; Dong YB; Elliott MJ; Wong SL; McMasters KM
Cancer Gene Ther; 2001 Apr; 8(4):241-51. PubMed ID: 11393276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]